Comparison of Edge Laminar Block and Serratus Posterior Superior Intercostal Plane Block for Postoperative Pain Management After VATS
Launched by DR ABDURRAHMAN YURTASLAN ANKARA ONCOLOGY TRAINING AND RESEARCH HOSPITAL · Jul 10, 2025
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to manage pain after a type of lung surgery called Video-Assisted Thoracoscopic Surgery (VATS). The study compares two nerve block techniques—Edge Laminar Block (ELB) and Serratus Posterior Superior Intercostal Plane Block (SPSIPB)—to see which one helps control pain better after surgery. Researchers will check how well each method reduces pain scores, the need for opioid pain medicines, side effects like nausea and vomiting, use of extra pain relief, and overall patient satisfaction. The goal is to find the best pain relief option for patients after this kind of surgery.
Adults between 18 and 75 years old who are scheduled for an elective VATS procedure and are in generally stable health may be eligible to join. People with allergies to local anesthetics, ongoing opioid use, bleeding problems, infections at the injection site, serious liver or kidney issues, pregnancy or breastfeeding, or those who can’t complete pain assessments won’t be able to participate. If you take part, you can expect to receive one of the two nerve block treatments during your surgery and be closely monitored for how well it controls your pain afterward. This study has not started recruiting yet, but it aims to help improve pain care for future patients undergoing this surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18-75 years Scheduled for elective video-assisted thoracoscopic surgery (VATS) American Society of Anesthesiologists (ASA) physical status I-III Ability to provide informed consen
- Exclusion Criteria:
- • Known allergy or contraindication to local anesthetics Chronic opioid use or chronic pain conditions Coagulopathy or use of anticoagulant therapy Infection at the injection site Severe hepatic or renal dysfunction Pregnancy or breastfeeding Inability to understand or complete pain assessment scales
About Dr Abdurrahman Yurtaslan Ankara Oncology Training And Research Hospital
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital is a leading institution dedicated to advancing cancer care and research in Turkey. With a strong focus on innovative oncology treatments and comprehensive training programs, the hospital serves as a pivotal center for clinical trials aimed at improving patient outcomes. Its multidisciplinary team of specialists collaborates to explore cutting-edge therapeutic approaches, ensuring adherence to the highest standards of clinical research and patient safety. The hospital's commitment to excellence positions it as a key player in the global oncology research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported